BPI20-022: Use of Cyclin Dependent Kinase 4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Metastatic Breast Cancer. Experience in a Third Level Hospital in Mexico City
- Resource Type
- Source
- Journal of the National Comprehensive Cancer Network. 18:BPI20-022
- Subject
Oncology biology business.industry Hormone receptor Cyclin-dependent kinase 4 Mexico city Cancer research medicine biology.protein HER2 negative medicine.disease business Metastatic breast cancer - Language
- ISSN
- 1540-1413
1540-1405